• Market Access in Europe: Bridging Regulatory and Health Technology Assessment (HTA) Gaps

    29 April 2016

    Read More

Confusion Pushes FDA to Change Antidepressant’s Brand Name

2 May 2016

Read More

EMA Finalizes Process Validation Guidance

2 May 2016

Read More

USTR: 97% of Counterfeit Drugs in US Shipped From Four Countries

2 May 2016

Read More

USTR: 97% of Counterfeit Drugs in US Shipped From Four Countries

2 May 2016

Read More

Genomic Data and Drug Development: EMA Offers New Draft Guidance

2 May 2016

Read More

Regulatory Recon: FDA Approves Acadia's Nuplazid to Treat Parkinson's Hallucinations; France Gets G7 to Weigh in on Drug Pricing (2 May 2016)

2 May 2016

Read More

FDA Slowly Chips Away at ANDA Backlog

2 May 2016

Read More

Updated: RAPS Calls for Board Nominations; Deadline Extended to 1 June

2 May 2016

Read More

EMA Reviewing Indian CRO Semler After FDA Warns of Data Integrity Issues

29 April 2016

Read More

Regulatory Recon: Zika Impact Worse Than Expected; Questions on Cancer Moonshot Coordination (29 April 2016)

29 April 2016

Read More